The Ebola outbreak in the Democratic Republic of the Congo (DRC) has claimed 600 lives, according to the latest figures released by the World Health Organization (WHO) on Thursday. The updated data show a sharp increase in fatalities, with the death toll crossing the 600-mark just three days after surpassing 500, underscoring the rapid spread of the disease in the central African nation. According to the WHO, there have been 1,759 laboratory-confirmed Ebola cases in the DRC since the outbreak was officially declared in mid-May. Of these, 600 patients have died, resulting in a case fatality rate of approximately 34 per cent. The figures, compiled using data provided by Congolese health authorities, indicate that while hundreds of people remain infected, the outbreak continues to expand and its full extent is yet to be determined.

The health crisis is centred in northeastern DRC, particularly in Ituri province, although cases have now been reported across four provinces. Health officials say the outbreak has posed significant logistical challenges due to the region's difficult terrain, ongoing insecurity and limited healthcare infrastructure, all of which have complicated efforts to trace contacts, isolate patients and contain transmission. Anne Ancia, the WHO's representative in the DRC, warned earlier this week that the epidemic remains far from under control. “The outbreak continues to expand, and its true scale has not yet been fully established,” she said, highlighting concerns that additional undetected infections may still exist in affected communities.

Alongside the confirmed cases, authorities are currently investigating 304 suspected Ebola infections to determine whether they are linked to the outbreak. Despite the rising death toll, health officials have also reported signs of recovery among some patients. According to the latest figures, 285 people infected with the virus have recovered after receiving medical care. In neighbouring Uganda, which has also recorded cases linked to the outbreak, two people have died, while 17 of the country's 20 confirmed patients have recovered. The current outbreak is being driven by the Bundibugyo strain of the Ebola virus, a relatively rare species for which there are currently no approved vaccines or specific treatments.

Also Read: 651 Indian Army Peacekeepers Receive UN Medals For Service In DR Congo

This distinguishes it from the more common Zaire strain, against which licensed vaccines have previously been deployed during outbreaks in Africa. The absence of approved medical countermeasures has increased the urgency of research efforts aimed at identifying effective therapies. In response, clinical trials evaluating two experimental treatments for Bundibugyo Ebola began in the DRC on July 2. Researchers hope the studies will determine whether the therapies can reduce mortality and improve recovery among infected patients. International health agencies, including the WHO, continue to support Congolese authorities by providing medical supplies, laboratory support, surveillance teams and community outreach programmes.

Ebola is a severe viral haemorrhagic fever transmitted through direct contact with the blood or bodily fluids of infected individuals or contaminated materials. Symptoms typically include fever, severe weakness, vomiting, diarrhoea and, in some cases, internal and external bleeding. Early diagnosis, supportive treatment and strict infection prevention measures can significantly improve survival rates. The WHO has urged continued vigilance as the outbreak evolves, stressing the importance of rapid case detection, contact tracing, safe burials and community awareness to limit further transmission. With the disease continuing to spread and investigations ongoing, health authorities remain focused on containing the outbreak while accelerating research into treatments for the Bundibugyo strain.

Also Read: WHO Sounds Alarm as Ebola Spreads to New Zones Across DRC Provinces